Sheau-Yan Ho1, Kelly J Rohan2, Justin Parent2, Felice A Tager3, Paula S McKinley3. 1. University of Vermont, Burlington, Vermont, USA. Electronic address: Sheau-Yan.Ho@uvm.edu. 2. University of Vermont, Burlington, Vermont, USA. 3. Columbia University Medical Center, New York, New York, USA.
Abstract
CONTEXT: Depression, fatigue, and sleep disturbances have been identified as a symptom cluster among breast cancer patients. However, few longitudinal studies have examined the temporal relations between these symptoms surrounding diagnosis and treatment. OBJECTIVES: The present study investigated the co-occurrence of and interrelations between nonsomatic depressive symptoms, fatigue, and sleep disturbances in breast cancer patients at three time points: before, after, and six to eight months following adjuvant chemotherapy treatment. METHODS: Separate samples of premenopausal (n = 67) and postmenopausal (n = 67) breast cancer patients completed self-report measures of depression, fatigue, and sleep disturbances at all three time points. Path analysis was used to explore within- and cross-symptom paths across time. RESULTS: Depression, fatigue, and sleep disturbances were correlated within each time point. Continuity paths, whereby prior levels of symptom severity tended to predict subsequent severity of the same symptom at the subsequent time point, were significant in both samples, except for depression in the premenopausal sample. Instead, significant cross-symptom paths emerged whereby baseline fatigue predicted postchemotherapy depression, and postchemotherapy fatigue predicted depression at follow-up in the premenopausal patients. No significant cross-symptom paths emerged for the postmenopausal sample. CONCLUSION: Findings supported the notion that depression, fatigue, and sleep disturbances manifest as a symptom cluster. Fatigue may precede nonsomatic symptoms of depression among premenopausal breast cancer patients and represents a potential intervention target.
CONTEXT: Depression, fatigue, and sleep disturbances have been identified as a symptom cluster among breast cancerpatients. However, few longitudinal studies have examined the temporal relations between these symptoms surrounding diagnosis and treatment. OBJECTIVES: The present study investigated the co-occurrence of and interrelations between nonsomatic depressive symptoms, fatigue, and sleep disturbances in breast cancerpatients at three time points: before, after, and six to eight months following adjuvant chemotherapy treatment. METHODS: Separate samples of premenopausal (n = 67) and postmenopausal (n = 67) breast cancerpatients completed self-report measures of depression, fatigue, and sleep disturbances at all three time points. Path analysis was used to explore within- and cross-symptom paths across time. RESULTS:Depression, fatigue, and sleep disturbances were correlated within each time point. Continuity paths, whereby prior levels of symptom severity tended to predict subsequent severity of the same symptom at the subsequent time point, were significant in both samples, except for depression in the premenopausal sample. Instead, significant cross-symptom paths emerged whereby baseline fatigue predicted postchemotherapy depression, and postchemotherapy fatigue predicted depression at follow-up in the premenopausal patients. No significant cross-symptom paths emerged for the postmenopausal sample. CONCLUSION: Findings supported the notion that depression, fatigue, and sleep disturbances manifest as a symptom cluster. Fatigue may precede nonsomatic symptoms of depression among premenopausal breast cancerpatients and represents a potential intervention target.
Authors: Julienne E Bower; Patricia A Ganz; Michael R Irwin; Lorna Kwan; Elizabeth C Breen; Steve W Cole Journal: J Clin Oncol Date: 2011-08-08 Impact factor: 44.544
Authors: Jesse R Fann; Anne M Thomas-Rich; Wayne J Katon; Deborah Cowley; Mary Pepping; Bonnie A McGregor; Julie Gralow Journal: Gen Hosp Psychiatry Date: 2008 Mar-Apr Impact factor: 3.238
Authors: Ann M Berger; Kimberly Wielgus; Melody Hertzog; Patricia Fischer; Lynne Farr Journal: Support Care Cancer Date: 2009-04-19 Impact factor: 3.603
Authors: Felice A Tager; Paula S McKinley; Freya R Schnabel; Mahmoud El-Tamer; Ying Keun K Cheung; Yixin Fang; Claire R Golden; Margery E Frosch; Ulya Habif; Margaret M Mulligan; Ivy S Chen; Dawn L Hershman Journal: Breast Cancer Res Treat Date: 2009-11-06 Impact factor: 4.872
Authors: Anita R Peoples; Sheila N Garland; Wilfred R Pigeon; Michael L Perlis; Julie Rya Wolf; Kathi L Heffner; Karen M Mustian; Charles E Heckler; Luke J Peppone; Charles S Kamen; Gary R Morrow; Joseph A Roscoe Journal: J Clin Sleep Med Date: 2019-01-15 Impact factor: 4.062
Authors: Andy S K Cheng; Yingchun Zeng; Xiangyu Liu; Shaxin Liu; Stella W C Cheng; Cindy T T Kwok; Raymond C K Chung; Jianfei Xie; Michael Feuerstein Journal: J Cancer Surviv Date: 2018-09-18 Impact factor: 4.442
Authors: Sarah A Marshall; Christopher C Yang; Qing Ping; Mengnan Zhao; Nancy E Avis; Edward H Ip Journal: Qual Life Res Date: 2015-10-17 Impact factor: 4.147
Authors: Eric S Zhou; Ann H Partridge; Karen L Syrjala; Alexis L Michaud; Christopher J Recklitis Journal: J Cancer Surviv Date: 2016-08-05 Impact factor: 4.442
Authors: Emma B Holliday; Nathan F Dieckmann; Tasha L McDonald; Arthur Y Hung; Charles R Thomas; Lisa J Wood Journal: Radiother Oncol Date: 2015-12-29 Impact factor: 6.280